Hologic (HOLX) EBITDA

Price: $61.38
Market Cap: $13.77B
Avg Volume: 2.46M
Country: US
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Beta: 0.975
52W Range: $60.34-84.67
Website: Hologic

What is Hologic's EBITDA?

  • Hologic's annual EBITDA is $1.30B.
  • Hologic's quarterly EBITDA is $352.00M.

What is EBITDA?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.

How is EBITDA calculated?

EBITDA is calculated using the following formula:

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Related Metrics

Other important metrics to assess Hologic's financial health include:

  • EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
    • Annual: 32.16%
    • Quarterly: 34.45%
  • Growth EBITDA - measures the annual growth rate of the company's EBITDA:
    • Annual: 16.71%
    • Quarterly: 7.28%
  • Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
    • Annual: 7.69%
    • Quarterly: 3.73%

These metrics provide insights into Hologic's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual EBITDA

$1.30B

Quarterly EBITDA

$352.00M

Hologic Historical EBITDA
EBITDA (Annual)
EBITDA (Quarterly)
$3.20B$3.20B$2.40B$2.40B$1.60B$1.60B$800.00M$800.00M$0.00$0.00-$800.00M-$800.00MEBITDA201620162017201720182018201920192020202020212021202220222023202320242024
Historical EBITDA Ratio (Annual)
51.24%51.24%40.99%40.99%30.74%30.74%20.49%20.49%10.25%10.25%0.00%0.00%EBITDA Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical EBITDA Ratio (Quarterly)
61.16%61.16%45.74%45.74%30.32%30.32%14.90%14.90%-0.52%-0.52%-15.95%-15.95%EBITDA Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025

Hologic Historical EBITDA Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year EBITDA Growth EBITDA EBITDA Ratio Growth EBITDA Ratio
2024 $1.30B 16.71% 32.16% 7.69%
2023 $1.11B -47.45% 29.87% -31.00%
2022 $2.11B -26.15% 43.28% -15.53%
2021 $2.86B 91.19% 51.24% 27.79%
2020 $1.50B 332.45% 40.09% 125.95%
2019 $346.10M 64.50% 17.74% -43.03%
2018 $210.40M -88.52% 31.14% 0.31%
2017 $1.83B 76.92% 31.05% -16.38%
2016 $1.04B 18.52% 37.13% 4.05%
2015 $874.10M 10.38% 35.69% 101.95%

Related Metrics

Explore detailed financial metrics and analysis for HOLX.